BioNTech SE (BNTX) Assets (2018 - 2025)
BioNTech SE (BNTX) reported Assets of $25.6 billion for Q4 2025, up 6.32% on a YoY basis from $24.1 billion in Q4 2024, and up 2.59% sequentially from $24.9 billion in Q3 2025.
BioNTech SE (BNTX) Assets (2018 - 2025) Analysis & Trends
BioNTech SE (BNTX) has 8 years of Assets data on file, last reported at $25.6 billion in Q4 2025.
- For the quarter ending Q4 2025, Assets rose 6.32% year-over-year to $25.6 billion; the trailing twelve-month figure through Dec 2025 stood at $25.6 billion (up 6.32% YoY), and the FY2025 full-year result was $24.8 billion, up 3.19% from the prior year.
- Assets climbed to $25.6 billion in Q4 2025, from $24.9 billion in the prior quarter.
- In the past five years, Assets ranged from a high of $25.6 billion in Q4 2025 to a low of $5.1 billion in Q1 2021.
- A 5-year average of $21.7 billion and a median of $23.8 billion in 2022 frame the typical range for Assets.
- Across the five-year window, Assets surged 927.56% in 2021 and dropped 7.85% in 2025, its largest moves.
- Tracing BNTX's Assets over 5 years: stood at $18.1 billion in 2021, then jumped by 31.15% to $23.8 billion in 2022, then gained by 4.22% to $24.8 billion in 2023, then fell by 2.74% to $24.1 billion in 2024, then gained by 6.32% to $25.6 billion in 2025.
- Business Quant data shows BNTX's Assets at $25.6 billion in Q4 2025, $24.9 billion in Q3 2025, and $24.5 billion in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 311.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 78.88 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.55 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 39.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.48 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.87 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 811.27 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 10.03 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.25 Bn |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn | 25.60 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25.60 Bn |
| Sep 30, 2025 | 24.95 Bn |
| Jun 30, 2025 | 24.49 Bn |
| Mar 31, 2025 | 22.28 Bn |
| Dec 31, 2024 | 24.08 Bn |
| Sep 30, 2024 | 24.60 Bn |
| Jun 30, 2024 | 23.95 Bn |
| Mar 31, 2024 | 24.18 Bn |
| Dec 31, 2023 | 24.75 Bn |
| Sep 30, 2023 | 24.17 Bn |
| Jun 30, 2023 | 24.20 Bn |
| Mar 31, 2023 | 23.70 Bn |
| Dec 31, 2022 | 23.75 Bn |
| Sep 30, 2022 | 22.85 Bn |
| Jun 30, 2022 | 22.57 Bn |
| Mar 31, 2022 | 22.78 Bn |
| Dec 31, 2021 | 18.11 Bn |
| Sep 30, 2021 | 16.78 Bn |
| Jun 30, 2021 | 11.02 Bn |
| Mar 31, 2021 | 5.07 Bn |